mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |